Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

SYSTEMIC LUPUS ERYTHEMATOSUS

Untangling the complexity of medication adherence in SLE

Suboptimal medication adherence, a major problem among individuals with systemic lupus erythematosus, is often more pronounced among minority racial groups. As the roots of racial disparities in treatment adherence are beginning to be untangled, the need for multidisciplinary, multilevel approaches to tackle this complex problem is emerging.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Factors associated with treatment adherence.

References

  1. Lim, S. S. & Drenkard, C. Epidemiology of lupus: an update. Curr. Opin. Rheumatol. 27, 427–432 (2015).

    Article  Google Scholar 

  2. Lim, S. S. et al. Racial disparities in mortality associated with systemic lupus erythematosus - Fulton and DeKalb counties, Georgia, 2002–2016. MMWR Morb. Mortal. Wkly Rep. 68, 419–422 (2019).

    Article  Google Scholar 

  3. Rhew, E. Y. et al. Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res. 153, 51–59 (2009).

    Article  Google Scholar 

  4. Drenkard, C. & Lim, S. S. Update on lupus epidemiology: advancing health disparities research through the study of minority populations. Curr. Opin. Rheumatol. 31, 689–696 (2019).

    Article  CAS  Google Scholar 

  5. Mehat, P. et al. Medication nonadherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res. 69, 1706–1713 (2017).

    Article  Google Scholar 

  6. Sun, K. et al. Racial disparities in medication adherence between African American and Caucasian patients with systemic lupus erythematosus and their associated factors. ACR Open Rheumatol. 2, 430–437 (2020).

    Article  Google Scholar 

  7. World Health Organization. Adherence to long-term therapies: evidence for action. World Health Organization https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf (2003).

  8. Feldman, C. H. et al. Medication nonadherence is associated with increased subsequent acute care utilization among Medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res. 67, 1712–1721 (2015).

    Article  CAS  Google Scholar 

  9. Heiman, E. et al. Depressive symptoms are associated with low treatment adherence in African American individuals with systemic lupus erythematosus. J. Clin. Rheumatol. 24, 368–374 (2018).

    Article  Google Scholar 

  10. Feldman, C. H. et al. Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus. Semin. Arthritis Rheum. 48, 205–213 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristina Drenkard.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drenkard, C., Feldman, C.H. Untangling the complexity of medication adherence in SLE. Nat Rev Rheumatol 16, 605–606 (2020). https://doi.org/10.1038/s41584-020-0490-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-020-0490-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing